Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors

NCT06684327 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06684327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06684327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Recruiting
Start date
November 30, 2024
Completion date
December 30, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paget disease, extramammary, penile cancer, rhabdomyosarcoma, testicular cancer, urachal cancer